Contextual Constrained Learning for Dose-Finding Clinical Trials

• URL: http://arxiv.org/abs/2001.02463v2
• Date: Mon, 24 Feb 2020 00:24:47 GMT
• Title: Contextual Constrained Learning for Dose-Finding Clinical Trials
• Authors: Hyun-Suk Lee, Cong Shen, James Jordon, Mihaela van der Schaar
• Abstract summary: C3T-Budget is a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. It recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group.
• Score: 102.8283665750281
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Clinical trials in the medical domain are constrained by budgets. The number of patients that can be recruited is therefore limited. When a patient population is heterogeneous, this creates difficulties in learning subgroup specific responses to a particular drug and especially for a variety of dosages. In addition, patient recruitment can be difficult by the fact that clinical trials do not aim to provide a benefit to any given patient in the trial. In this paper, we propose C3T-Budget, a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. The algorithm aims to maximize drug efficacy within the clinical trial while also learning about the drug being tested. C3T-Budget recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group, such as the population distribution, estimated expected efficacy, and estimation credibility. In addition, the algorithm aims to avoid unsafe dosages. These characteristics are further illustrated in a simulated clinical trial study, which corroborates the theoretical analysis and demonstrates an efficient budget usage as well as a balanced learning-treatment trade-off.

Related papers

• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Language Interaction Network for Clinical Trial Approval Estimation [37.60098683485169]
  We introduce the Language Interaction Network (LINT), a novel approach that predicts trial outcomes using only the free-text descriptions of the trials. We have rigorously tested LINT across three phases of clinical trials, where it achieved ROC-AUC scores of 0.770, 0.740, and 0.748.
  arXiv  Detail & Related papers  (2024-04-26T14:50:59Z)
• TrialDura: Hierarchical Attention Transformer for Interpretable Clinical Trial Duration Prediction [19.084936647082632]
  We propose TrialDura, a machine learning-based method that estimates the duration of clinical trials using multimodal data. We encode them into Bio-BERT embeddings specifically tuned for biomedical contexts to provide a deeper and more relevant semantic understanding. Our proposed model demonstrated superior performance with a mean absolute error (MAE) of 1.04 years and a root mean square error (RMSE) of 1.39 years compared to the other models.
  arXiv  Detail & Related papers  (2024-04-20T02:12:59Z)
• Zero-Shot Clinical Trial Patient Matching with LLMs [40.31971412825736]
  Large language models (LLMs) offer a promising solution to automated screening. We design an LLM-based system which, given a patient's medical history as unstructured clinical text, evaluates whether that patient meets a set of inclusion criteria. Our system achieves state-of-the-art scores on the n2c2 2018 cohort selection benchmark.
  arXiv  Detail & Related papers  (2024-02-05T00:06:08Z)
• Uncertainty Quantification in Neural-Network Based Pain Intensity Estimation [0.0]
  The evaluation of pain intensity is challenging because different individuals experience pain differently. This study presents a neural network-based method for objective pain interval estimation.
  arXiv  Detail & Related papers  (2023-11-14T22:14:07Z)
• A Flexible Framework for Incorporating Patient Preferences Into Q-Learning [1.2891210250935146]
  In real-world healthcare problems, there are often multiple competing outcomes of interest, such as treatment efficacy and side effect severity. statistical methods for estimating dynamic treatment regimes (DTRs) usually assume a single outcome of interest. This includes restrictions to a single time point and two outcomes, the inability to incorporate self-reported patient preferences and limited theoretical guarantees.
  arXiv  Detail & Related papers  (2023-07-22T08:58:07Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• Towards Fair Patient-Trial Matching via Patient-Criterion Level Fairness Constraint [50.35075018041199]
  This work proposes a fair patient-trial matching framework by generating a patient-criterion level fairness constraint. The experimental results on real-world patient-trial and patient-criterion matching tasks demonstrate that the proposed framework can successfully alleviate the predictions that tend to be biased.
  arXiv  Detail & Related papers  (2023-03-24T03:59:19Z)
• Adaptive Identification of Populations with Treatment Benefit in Clinical Trials: Machine Learning Challenges and Solutions [78.31410227443102]
  We study the problem of adaptively identifying patient subpopulations that benefit from a given treatment during a confirmatory clinical trial. We propose AdaGGI and AdaGCPI, two meta-algorithms for subpopulation construction.
  arXiv  Detail & Related papers  (2022-08-11T14:27:49Z)
• Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraints [84.09488581365484]
  Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds becomes more complex. Most commonly used methods in practice focus on identifying a Maximum Tolerated Dose (MTD) by learning only from toxicity events. We present a novel adaptive clinical trial methodology that aims at maximizing the cumulative efficacies while satisfying the toxicity safety constraint with high probability.
  arXiv  Detail & Related papers  (2020-06-09T03:06:45Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.